| MEDEXUS PHARMACEUTIC. |
| Kanada |
| Gesundheit |
| CA58410Q2036 / A2PA3U |
| P731 (Frankfurt) |
| FRA:P731, ETR:P731, P731:GR |
| - |
| https://www.medexus.com/ |
|
Medexus Pharmaceuticals Inc. is a North American specialty pharmaceutical company that primarily focuses on providing innovative and niche products within the realms of hematology, autoimmune diseases, and allergy markets. Its portfolio includes both..
>Volltext.. |
| 70.2 Mio. EUR |
| 78.96 Mio. EUR |
| 86.67 Mio. EUR |
| 11.1 Mio. EUR |
| -0.25 Mio. EUR |
| -0.01 EUR |
| 21.67 Mio. EUR |
| 12.8 Mio. EUR |
| 13.03 Mio. EUR |
| 0.24 |
| -7.44% |
| -108.22% |
| - |
| - |
| - |
| - |
| MEDEXUS |
| 08.04.26 |
|